VRAL Compelling technology and IP as evidence by this tiny Company’s ability to attract some of the world’s most successful scientist and businessmen: http://21webir.com/stocks-and-sectors/follow-up-profile-coverage-of-viral-genetics/

For those willing and able to take the risk take advantage of the current opportunity and be patient!! When the stock moves it will be violent In June of last year the stock popped 550% in a 6 week period … Continue reading →

Profile Report July 6, 2010 21st Century Investor Relations, Inc, is an Investor Relations 2.0  firm that helps small and micro cap companies build investor audiences through the use of Internet marketing and Social Media(“Investor Relations 2.0” or “IR 2.0”). We … Continue reading →

VRAL potential 10-50 fold winner in the next 18-36 months!! http://21webir.com/stocks-and-sectors/disclaimer-for-viral-genetics-vral-pink-sheets/

Follow up VRAL Report to be released after the market close: http://21webir.com/stocks-and-sectors/disclaimer-for-viral-genetics-vral-pink-sheets/

If you haven’t already done so please sign up for our free email alerts: http://www.21webir.com/subscribe-news-letter.html

Viral Genetics, Inc. (VRAL: Pink Sheets) Viral Genetics, Inc. is a biotechnology company that discovers and develops immune-based therapies for HIV and AIDS using its thymus nuclear protein compound (TNP) and more recently experimentally and computationally derived targeted peptides. The … Continue reading →

Viral Genetics, Inc (VRAL: Pink Sheets) 21st Century Investor Relations, Inc, is an Investor Relations 2.0  firm that helps small and micro cap companies build investor audiences through the use of Internet marketing and Social Media (“Investor Relations 2.0” or … Continue reading →

We have a follow up piece of our initial April 12, 2010 profile report coming out in the next few days. VRAL trading at its support level is an ideal accumulation point for those looking to build a position in … Continue reading →